OBINUTUZUMAB - INJECTION
PHONETIC PRONUNCIATION: (OH-bi-nue-TOOZ-ue-mab)
COMMON BRAND NAME(S): Gazyva
GENERIC NAME(S): obinutuzumab
Uses
USES: Obinutuzumab is used to treat certain types of blood cancer (such as chronic lymphocytic leukemia, follicular lymphoma). Obinutuzumab belongs to a class of drugs known as monoclonal antibodies. It works by stopping the growth of cancer cells.
How to use OBINUTUZUMAB - INJECTION
HOW TO USE: This medication is given by injection into a vein by a health care professional. It is given as directed by your doctor. Your doctor may direct you to receive this medication in a treatment cycle (for example, only on certain days each month). Carefully follow your doctor's instructions. The dosage is based on your medical condition and response to treatment. Obinutuzumab may cause very serious infusion-related reactions during or up to 24 hours after treatment. These reactions occur more often with the first and second treatments. Your doctor will monitor you closely and increase your dose slowly to reduce the chance of these serious side effects. Your doctor may also prescribe other medications before each treatment, including acetaminophen, an antihistamine (such as diphenhydramine), and a corticosteroid (such as methylprednisolone) to prevent these side effects. If you have a reaction, your treatment may be temporarily stopped. Tell your doctor or nurse right away if any of these side effects occur: dizziness, fainting, fast heartbeat, chest pain, trouble breathing, wheezing, itching/swelling of the throat, nausea, vomiting, diarrhea, flushing, headache, fever, or chills. If you take drugs for high blood pressure, ask your doctor ahead of time if you should change the way you take your blood pressure medication right before and after your dose of obinutuzumab. Some people have had reactions (such as dizziness/fainting) due to taking blood pressure medication too close to the time of their obinutuzumab infusion.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for OBINUTUZUMAB - INJECTION
Obinutuzumab is a medication used to treat certain types of cancer, such as chronic lymphocytic leukemia (CLL) and follicular lymphoma. It is given by injection into a vein.
Obinutuzumab belongs to a class of medications called monoclonal antibodies. It works by targeting and binding to specific proteins on cancer cells, which helps the immune system to identify and destroy those cells.
Obinutuzumab is administered through an intravenous (IV) infusion, meaning it is injected into a vein over a specific period of time. The exact dose and schedule will depend on the specific condition being treated.
Common side effects of Obinutuzumab can include infusion-related reactions (fever, chills, nausea), low blood cell counts, infections, tiredness, cough, diarrhea, and muscle or joint pain. It is important to discuss any side effects with your healthcare provider.
The duration of Obinutuzumab treatment can vary depending on the individual's response and the specific type of cancer being treated. It may be given as a single treatment or as a series of treatments over several months.
Before starting Obinutuzumab, it is important to inform your healthcare provider about any allergies, current medications, or medical conditions you may have. Obinutuzumab may not be suitable for individuals with certain infections or weakened immune systems.
Obinutuzumab may harm an unborn baby and should not be used during pregnancy unless specifically prescribed by a healthcare professional. It is also not recommended to breastfeed while receiving Obinutuzumab.
Warning
WARNING: Obinutuzumab may cause serious (possibly fatal) liver disease in people who have a current or past infection with hepatitis B. Before starting treatment with this medication, your doctor should order a test to see if you have hepatitis B. Your doctor may also order blood tests and watch for symptoms of liver disease during treatment and for several months after your last dose of medication. Get medical help right away if you have any symptoms of liver damage, including: dark urine, persistent nausea/vomiting/loss of appetite, stomach/abdominal pain, yellowing eyes/skin. Obinutuzumab may increase your risk of getting a rare but very serious (sometimes fatal) brain infection (progressive multifocal leukoencephalopathy-PML). Get medical help right away if any of these rare but very serious side effects occur: confusion, dizziness, loss of balance, difficulty talking/walking, vision changes.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet